SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-23-000067
Filing Date
2023-04-06
Accepted
2023-04-06 16:10:54
Documents
15
Period of Report
2023-04-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20230406.htm   iXBRL 8-K 32563
2 EX-99.1 ooliveoilpressrelease.htm EX-99.1 5722
6 ooliveoilpressrelease001.jpg GRAPHIC 162321
7 ooliveoilpressrelease002.jpg GRAPHIC 136603
  Complete submission text file 0001005286-23-000067.txt   581204

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20230406.xsd EX-101.SCH 1981
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20230406_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20230406_pre.xml EX-101.PRE 12589
9 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20230406_htm.xml XML 4081
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 23806279
SIC: 2834 Pharmaceutical Preparations